K161177 is an FDA 510(k) clearance for the Axiom PX. Classified as Implant, Endosseous, Root-form (product code DZE), Class II - Special Controls.
Submitted by Anthogyr Sas (Sallanches, FR). The FDA issued a Cleared decision on June 15, 2017 after a review of 415 days - an unusually long review period, suggesting complex equivalence evaluation.
This device falls under the Dental FDA review panel, regulated under 21 CFR 872.3640 - the FDA dental device regulatory framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.
Device pattern: High-complexity regulatory submission. Standards-verified equivalence. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Dental submissions.
View all Anthogyr Sas devices